Near Infrared Fluorescence Imaging for Bladder Cancer Detection



Status:Completed
Conditions:Cancer, Cancer, Bladder Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:2/17/2019
Start Date:November 28, 2017
End Date:July 25, 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Pilot Study: Assessing Near Infrared Fluorescence Imaging Medical Technology for the Detection of Bladder Cancer

The primary outcome of this study is to determine the minimal dwell time needed for adequate
detection of hexaminolevinulate HCL avid tumors using protoporphyrin IX (PpIX) near infrared
fluorescence (NIRF).


Inclusion Criteria:

- Diagnosis of bladder mass on office cystoscopy suspicious for malignancy, either newly
diagnosed or a recurrent tumor.

- Planned transurethral resection of bladder tumor in the operating room.

- Ability to give informed consent.

- Willing to spend time for the study

- Men or women (age 18 or older)

- Any racial or ethnic origin

Exclusion Criteria:

- Pregnancy

- Nursing mother

- Diagnosis of porphyria

- Gross hematuria

- BCG immunotherapy or intravesical chemotherapy within the past 90 days

- Known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid
We found this trial at
1
site
Univ of Rochester Medical Center
601 Elmwood Avenue
Rochester, New York 14642
(585) 275-2100
Phone: 585-275-0998
Univ of Rochester Medical Center One of the nation's top academic medical centers, the University...
?
mi
from
Rochester, NY
Click here to add this to my saved trials